Nakajima and colleagues had described a galectin-3-dependent activation of Notch1 signaling in a system that models tumor cell/osteoblast and osteoclast interactions, critical events in the maintenance of bone metastasis found in different cancers, such as breast and prostate cancers. This evidence concerns the gene LGALS3 and Familial prostate cancer.